Bolli will lead worldwide business development for the company’s Contract Development and Manufacturing Organisation (CDMO) services
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
The goal is to better support drug developers as programs move from laboratory research into clinical trials
Multi-year CDMO partnership combines AI-led virtual development, precision chemistry and GMP manufacturing to accelerate five high-science APIs across regulated markets
Samsung Biologics will continue supplying products previously manufactured at the site to GSK
The CDMO Leadership Awards spotlight top-performing development and manufacturing service providers
The milestone moves the company closer to its previously announced $120 million US expansion, with groundbreaking slated for late 2026
The move comes as the global biotech and biopharma CDMO market continues to surge, fueled by rising demand
The new equipment will be installed at Codis’ 400,000-square-foot Haverhill facility and is expected to be operational by 2027
The first of four planned modules at the new plant is expected to come online by summer 2026
Subscribe To Our Newsletter & Stay Updated
